Antihydrogen neutral as charged, Marquette researcher finds
Research conducted at CERN laboratory near Geneva, Switzerland
MILWAUKEE — The charge of antihydrogen – the antimatter counterpart of hydrogen – is neutral, according to a paper published this week by a team of scientists that includes a research assistant professor of physics at Marquette University.
Dr. Timothy Tharp and 38 other colleagues conducted research as part of the ALPHA Collaboration at the CERN laboratory near Geneva, Switzerland, to reach the findings published this week in the scientific journal Nature.
The ongoing research at CERN may help the scientists resolve the long-standing question of why there appears to be so much more matter than antimatter in the observable universe.
According to the Standard Model of particle physics, the charge of antihydrogen should be neutral. However, it was difficult to test because producing antimatter and measuring its properties is experimentally challenging.
“We expected antihydrogen to be electrically neutral – the same as hydrogen – but this hadn’t been tested previously,” said Tharp, who joined Marquette for the spring 2016 semester and was with Aarhus University when conducting the research at CERN.
Tharp and his colleagues studied trapped atoms of antihydrogen and provided new evidence for their charge neutrality, improving measurement precision by a factor of 20 compared to previous measurements.
Since the charge of the antiproton – the antimatter counterpart of the proton – is known to relatively high precision, the result helps to refine the bound on the charge of the positron – the antimatter counterpart of the electron.
Recent Press Releases by Marquette University
New Marquette Law School Poll finds many Wisconsin primary voters undecided, unfamiliar with candidatesJun 20th, 2018 by Marquette University
Walker, Baldwin hold modest advantages over challengers
Grant will fund Dr. Murray Blackmore’s next phase of study
Twohey, who worked as a reporter at the Milwaukee Journal Sentinel from 2003 to 2007, has focused much of her attention on the treatment of women and children.